Hypoxia Induced Tumor Metabolic Switch Contributes to Pancreatic Cancer Aggressiveness
Pancreatic ductal adenocarcinoma remains one of the most lethal of all solid tumors with an overall five-year survival rate of only 3–5%. Its aggressive biology and resistance to conventional and targeted therapeutic agents lead to a typical clinical presentation of incurable disease once diagnosed....
Main Authors: | Juan L. Iovanna, Sophie Vasseur, Richard Tomasini, Roselyne Tournaire |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/2/4/2138/ |
Similar Items
-
Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more
by: Xiaodong Hao, et al.
Published: (2021-09-01) -
Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302
by: Wojtkowiak, Jonathan W., et al.
Published: (2016) -
Pancreatic Cancer and Cachexia—Metabolic Mechanisms and Novel Insights
by: Kalliopi Anna Poulia, et al.
Published: (2020-05-01) -
Inhibition of the Receptor for Advanced Glycation End Products Enhances the Cytotoxic Effect of Gemcitabine in Murine Pancreatic Tumors
by: Priyanka Swami, et al.
Published: (2021-04-01) -
Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential
by: Knudsen, Erik S., et al.
Published: (2015)